Information on tumor mutational status was limited before the development of NGS because traditional Sanger sequencing and ...

Illumina, Inc. ILMN has announced a collaboration with NVIDIA NVDA to advance technology platforms for analyzing and interpreting multiomic data. By combining advancements in artificial intelligence ...

The Perlmutter Cancer Center at New York City-based NYU Langone Health recently launched its new Center for Molecular Oncology, naming Shridar Ganesan, MD, PhD, as director. The center will manage, ...

Nvidia introduced the Blackwell GPU architecture to support the next generation of RTX 50-series g. This new architecture builds upon the Ada Lovelace design, offering enhancements aimed at improving ...

Illumina & NVIDIA collaborate to decode biology and propel precision health: San Diego Wednesday, January 15, 2025, 16:00 Hrs [IST] Illumina, Inc., a global leader in genomic sequ ...

Illumina launches pilot proteomics programme with UK Biobank and biopharma collaborators to analyze 50,000 samples: San Diego Tuesday, January 14, 2025, 13:00 Hrs [IST] Illumina, ...

Explore how precision medicine is reshaping healthcare with tools like genetic testing, NGS, wearables, and organoids for ...

This meta-analysis sheds more light on the beneficial impact of multiple melanoma (MM) treatments and the predictive value of ...

Illumina, Inc. , a global leader in genomic sequencing and analysis, today announced it is collaborating with NVIDIA to advance technology platforms for the analysis and interpretation of multiomic ...

Revvity, Inc. (NYSE: RVTY), today announced a strategic agreement to commercialize an in vitro diagnostic (IVD) workflow ...

Platinum Pro is Quantum-Si’s newest Next-Generation Protein Sequencer™ built from the foundation of innovation established by ...

The global next generation molecular assay market is poised for significant growth, with an expected valuation of USD ...